{
    "paper_id": "2a56ad2762f0fa7301bdd103109f853281bf1ca6",
    "metadata": {
        "title": "Ministry of Health of, the Russian Federation",
        "authors": [
            {
                "first": "B",
                "middle": [],
                "last": "Solun",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hasharon Hospital",
                    "location": {
                        "settlement": "Petah Tikva"
                    }
                },
                "email": ""
            },
            {
                "first": "Y",
                "middle": [],
                "last": "Shoenfeld",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of the Mosaics of Autoimmunity",
                    "institution": "Tel-Aviv University",
                    "location": {
                        "country": "Israel"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Inhibition of metalloproteinases in therapy for severe lung injury due 3 to COVID-19 20 Since its first appearance in December 2019 in the Chinese province of Wuhan, COVID-19 has spread rapidly through-21 out the world and poses a serious threat to public health. Acute respiratory failure due to widespread lung inflamma-22 tion progress to acute respiratory distress syndrome (ARDS) with an altered pulmonary and alveolar function that can 23 lead to disability, prolong hospitalizations, and adverse outcomes. 24 While there is no specific treatment for severe acute lung injury (ALI) and ARDS due to the COVID-19 and the manage-25 ment is mostly supportive, it is very important to better understand the pathophysiological processes activated by the 26 inflammatory mediators such as cytokines and metalloproteinases with the aim of their subsequent inhibition in the 27 course of the complex treatment. 28 Herein, we will discuss the pathophysiological mechanisms of ALI/ARDS, with a focus on the pivotal role played by 29 matrix metalloproteinases (MMP) and the kinin-kallikrein system (KKS), and the effects of the possible pharmacolog-30 ical interventions. 31 Aprotinin is a nonspecific protease inhibitor especially of trypsin, chymotrypsin, plasmin, and kallikrein, and it is many 32 years in clinical use. Aprotinin inhibits the release of pro-inflammatory cytokines and involved in the process of glyco-33 protein homeostasis. Experimental data support the hypothesis that the use of aprotinin to inhibit MMPs and KKS may 34 be a new potential approach to the treatment of ALI / ARDS. The current treatment of COVID-19 disease is mostly supportive, and re-62 spiratory failure due to ALI/ARDS is the leading cause of death [1] . [2] . Recently published studies from China regarding the epi-68 demiological and clinical characteristics of patients with COVID-19 disease 69 revealed a wide difference (from 17 to 67%) in the incidence of ARDS with 70 a mortality rate of up to 52,4% [3] [4] [5] [6] .",
            "cite_spans": [
                {
                    "start": 85,
                    "end": 87,
                    "text": "20",
                    "ref_id": null
                },
                {
                    "start": 513,
                    "end": 515,
                    "text": "24",
                    "ref_id": null
                },
                {
                    "start": 908,
                    "end": 910,
                    "text": "28",
                    "ref_id": null
                },
                {
                    "start": 1736,
                    "end": 1739,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1742,
                    "end": 1745,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1995,
                    "end": 1998,
                    "text": "[3]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1999,
                    "end": 2002,
                    "text": "[4]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2003,
                    "end": 2006,
                    "text": "[5]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 2007,
                    "end": 2010,
                    "text": "[6]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "According to the recent US Centre's for Disease Control and Prevention 72 (CDC) statistics since mid-March, the fatality rates in the US from COVID- 73 19 was highest in patients aged \u226585, ranging from 10% to 27%, followed 74 by 3% to 11% among persons aged 65-84 years, 1% to 3% among those 75 aged 55-64 years and < 1% among persons aged 20-54 years [7] . 76 Significant progress has been made recently in understanding the epide-77 miology, pathogenesis, and treatment of ALI and ARDS. However, more 78 efforts are needed to further reduce mortality and morbidity from these dis- In this review, we will discuss the pathophysiological mechanisms of 85 ALI, with a focus on the pivotal role of matrix metalloproteinases and the 86 kinin-kallikrein system in this process. We will also review, whether 87 aprotinin, as a nonspecific protease inhibitor, be useful in treating ALI. nuclear factor kappa B [11, 12] . These mediators activate alveolar macro-95 phages and neutrophils, which release oxygen radicals and proteolytic 96 enzymes and produce further lung tissue damage. Indeed, increased pulmo-97 nary vascular permeability caused by activated neutrophils, oxygen radi-98 cals, and proteases seem the fundamental cause of ALI [13] .",
            "cite_spans": [
                {
                    "start": 149,
                    "end": 151,
                    "text": "73",
                    "ref_id": null
                },
                {
                    "start": 352,
                    "end": 355,
                    "text": "[7]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 358,
                    "end": 360,
                    "text": "76",
                    "ref_id": null
                },
                {
                    "start": 904,
                    "end": 908,
                    "text": "[11,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 909,
                    "end": 912,
                    "text": "12]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1235,
                    "end": 1239,
                    "text": "[13]",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "71"
        },
        {
            "text": "Neutrophils are the prototypic cells of the immune system with their 100 primary function of host defense and eradication of invading microbial 101 pathogens [14] . These functions are accomplished by activation of immune 102 receptors, such as toll-like receptors and other recognition receptors 103 [15, 16] . An important component of this process is the differentiation 104 and activation of T helper lymphocytes of the Th1 and Th2 phenotypes 105 with overproduction of their cytokines including IL-3, IL-4, IL-5, IL-6, 106 IL-9, IL-10 and IL-13 [17] .",
            "cite_spans": [
                {
                    "start": 158,
                    "end": 162,
                    "text": "[14]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 301,
                    "end": 305,
                    "text": "[15,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 306,
                    "end": 309,
                    "text": "16]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 550,
                    "end": 554,
                    "text": "[17]",
                    "ref_id": "BIBREF29"
                }
            ],
            "ref_spans": [],
            "section": "99"
        },
        {
            "text": "Increased levels of cytokines are a usual finding in the sputum of pa-108 tients with acute inflammatory lung processes [18] [19] [20] . IL-13 and IL-6 109 from activated mast cells play an important role in various inflammatory 110 lung diseases and induced matrix contraction [21] [22] [23] . IL-13, as well as a 111 vascular endothelial growth factor, are known as potent mediators of tissue 112 fibrosis and key regulators of the cellular matrix [24,25].",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 124,
                    "text": "[18]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 125,
                    "end": 129,
                    "text": "[19]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 130,
                    "end": 134,
                    "text": "[20]",
                    "ref_id": null
                },
                {
                    "start": 278,
                    "end": 282,
                    "text": "[21]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 283,
                    "end": 287,
                    "text": "[22]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 288,
                    "end": 292,
                    "text": "[23]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "107"
        },
        {
            "text": "Mild cases of COVID-19 sometimes are rapidly turning into severe cases, 114 with lower respiratory tract infections. This may be due to the \"cytokine 115 storm\". Cytokine storm is a group of disorders representing a variety of in-116 flammatory etiologies known as systemic inflammatory response syn-117 drome, cytokine release syndrome, macrophage activation syndrome, and 118 hemophagocytic lymphohistiocytosis [26] . the key role of kinins in the respiratory tract pathophysiology [48] . They reported about 31% incidence of thrombotic complications [49] . ",
            "cite_spans": [
                {
                    "start": 413,
                    "end": 417,
                    "text": "[26]",
                    "ref_id": null
                },
                {
                    "start": 484,
                    "end": 488,
                    "text": "[48]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 553,
                    "end": 557,
                    "text": "[49]",
                    "ref_id": "BIBREF70"
                }
            ],
            "ref_spans": [],
            "section": "113"
        },
        {
            "text": "193 the cow parotid gland in 1930. In 1964 it was purified from bovine lung 194 tissue. Aprotinin acts as a nonspecific serine protease inhibitor -especially 195 trypsin, chymotrypsin, plasmin, and kallikrein [50] . The antikallikrein 196 action of aprotinin leads to the inhibition of factor XIIa formation, inhibi-197 tion of the intrinsic pathway of coagulation, fibrinolysis, thrombin genera-198 tion, and to the attenuation of the pro-inflammatory response [51] .",
            "cite_spans": [
                {
                    "start": 209,
                    "end": 213,
                    "text": "[50]",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 462,
                    "end": 466,
                    "text": "[51]",
                    "ref_id": "BIBREF72"
                }
            ],
            "ref_spans": [],
            "section": "113"
        },
        {
            "text": "Aprotinin inhibits proinflammatory cytokine release and maintains 200 glycoprotein homeostasis. In platelets, aprotinin reduces glycoprotein 201 loss, while in granulocytes it prevents the expression of pro-inflammatory 202 adhesive glycoproteins [52] .",
            "cite_spans": [
                {
                    "start": 247,
                    "end": 251,
                    "text": "[52]",
                    "ref_id": "BIBREF73"
                }
            ],
            "ref_spans": [],
            "section": "199"
        },
        {
            "text": "The systemic inflammatory response is a common phenomenon that oc-204 curs in most patients undergoing coronary artery bypass graft (CABG) sur-205 gery. Acute activation of the complement system, as well as activation of 206 the coagulation and fibrinolytic systems lead to multiorgan inflammatory 207 damage. Using aprotinin, as a nonspecific serine protease inhibitor, not 208 only decreases the bleeding tendency but may also attenuate the systemic 209 inflammatory response as well [53] .",
            "cite_spans": [
                {
                    "start": 486,
                    "end": 490,
                    "text": "[53]",
                    "ref_id": "BIBREF74"
                }
            ],
            "ref_spans": [],
            "section": "203"
        },
        {
            "text": "In the study of Tain-Yen Hsia et al. aprotinin more effectively reduced 211 the levels of MMPs and cytokines than tranexamic acid in infants after car-212 diac surgery [54] . 213 Aprotinin is approved by the US Food and Drug Administration (FDA) 214 as an agent that effectively prevents blood loss and transfusion during cor-215 onary artery bypass graft surgery [51] .",
            "cite_spans": [
                {
                    "start": 168,
                    "end": 172,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 175,
                    "end": 178,
                    "text": "213",
                    "ref_id": null
                },
                {
                    "start": 364,
                    "end": 368,
                    "text": "[51]",
                    "ref_id": "BIBREF72"
                }
            ],
            "ref_spans": [],
            "section": "210"
        },
        {
            "text": "In 2007 the drug use was temporarily discontinued due to increased 217 risk of complications and death after Bayer Health Care has published 218 the follow-up study [55] . Moreover, in a randomized controlled study, 219 Blood Conservation Using Antifibrinolytics in a Randomized Trial (BART) 220 Fergusson et al. reported a higher mortality rate in the aprotinin-treated pa-221 tients. However, the subsequent analysis identified methodological re-222 search flaws making the findings of the cardiovascular risks from the 223 BART study controversial [56] . In 2012 the European Medicines Agency 224 (EMA) scientific committee reinstated its previous view regarding aprotinin 225 and has recommended it for further use [57] . Since that time the Nordic 226 Group became a distributor of aprotinin [58] .",
            "cite_spans": [
                {
                    "start": 165,
                    "end": 169,
                    "text": "[55]",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 551,
                    "end": 555,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 676,
                    "end": 679,
                    "text": "225",
                    "ref_id": null
                },
                {
                    "start": 719,
                    "end": 723,
                    "text": "[57]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 797,
                    "end": 801,
                    "text": "[58]",
                    "ref_id": "BIBREF81"
                }
            ],
            "ref_spans": [],
            "section": "216"
        },
        {
            "text": "Nevertheless, we do not recommend to use aprotinin for treatment 228 COVID-19 induced ALI/ARDS in patients after CABG, acute coronary syn-229 drome, cerebrovascular events, renal failure, or concomitant use of 230 aminoglycosides.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "227"
        },
        {
            "text": "Since deep vein thrombosis (DVT) is a known complication in hospital-232 ized patients with COVID-19 disease [59] , we recommend using Clexane 233 (Enoxaparin sodium) twice daily injections of 100 IU/kg (1 mg/kg) simul-234 taneously with the aprotinin treatment.",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 113,
                    "text": "[59]",
                    "ref_id": "BIBREF83"
                }
            ],
            "ref_spans": [],
            "section": "231"
        },
        {
            "text": "In a small experimental study of Svartholm et al., the authors used 236 aprotinin on laboratory pigs with septic shock. They concluded that 237 aprotinin attenuated the effects on coagulation, fibrinolytic systems, and 238 cardiopulmonary hemodynamic, seriously impaired due to septic shock 239 [60]. Currently, there is no clinical evidence supporting the use of aprotinin 248 in COVID-19 patients. Therefore, further clinical studies should be con-249 ducted to verify it's effectiveness in patients with COVID 19. 250 ",
            "cite_spans": [
                {
                    "start": 517,
                    "end": 520,
                    "text": "250",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "235"
        },
        {
            "text": "The pathophysiological mechanism of ALI/ARDS includes a cascade of 252 local and systemic responses with activation of numerous proinflammatory 253 cytokines and mediators. Between them, matrix metalloproteinases and 254 kinin-kallikrein system play a pivotal role in the pathological process. Over-255 expression of MMPs leads to destructive tissue injury and tissue remodel-256 ing. Experimental data suggest the hypothesis that MMPs may be a new 257 potential target for therapy of ALI/ARDS. Aprotinin as a nonspecific prote-258 ase inhibitor is many years in clinical use. It does not only decrease the 259 bleeding tendency by inhibition of the kinin-kallikrein system but also 260 attenuated systemic inflammatory response due to decreased level of in-261 flammatory cytokines and MMPs. Based on these data, we think that 262 aprotinin may be a hopeful therapeutic agent in the complex treatment of 263 ALI and a good area for further investigations and clinical trials.",
            "cite_spans": [
                {
                    "start": 683,
                    "end": 686,
                    "text": "260",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "251"
        },
        {
            "text": "Conflict of interest 265 The authors declare that they have no competing interests. ",
            "cite_spans": [
                {
                    "start": 21,
                    "end": 24,
                    "text": "265",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "264"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Clinical predictors of mortality due to COVID-19 from Wuhan, China",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Intensive Care Med",
            "volume": "274",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Characteristics of and important lessons from the Coronavirus dis-276",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mcgoogan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "COVID-19) outbreak in China: summary of a report of 72",
            "authors": [],
            "year": 2019,
            "venue": "",
            "volume": "314",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Chinese center for disease control and prevention JAMA",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.2648"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Epidemiological and clinical characteristics of 99 cases 280 of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "281",
            "issn": "",
            "pages": "507--520",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Clinical features of patients infected with",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "China Lancet",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ronavirus In Wuhan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "395",
            "issn": "",
            "pages": "497--506",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Clinical course and outcomes of critically ill patients with 285",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "China: a single-centered, retrospective, observa-286 tional study",
            "authors": [],
            "year": 2020,
            "venue": "SARS-CoV-2 pneumonia in Wuhan",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Risk Factors Associated with Acute Respiratory Distress Syn-288",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "drome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Severe Outcomes Among Patients with Coronavirus Disease",
            "authors": [],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Mor-293 bidity and Mortality Weekly Report (MMWR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Acute Lung Injury: Epidemiology, Pathogenesis, and Treat-295",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Matthay",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "The epithelium in acute lung injury/acute respiratory 297 distress syndrome",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Gropper",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wiener-Kronish",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Curr Opin Crit Care",
            "volume": "14",
            "issn": "1",
            "pages": "11--16",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Epithelial cell apoptosis and lung remodeling",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuwano",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cell Mol Immunol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Serological Assays for SARS-CoV-2 Infectious 301",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Infantino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Damiani",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Gobbi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Disease: Benefits, Limitations, and Perspectives.IMAJ",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "22",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Increased expression of nuclear factor-kappaB 303",
            "authors": [
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Stefano",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Caramori",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Oates",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "in bronchial biopsies from smokers and patients with COPD",
            "authors": [],
            "year": 2002,
            "venue": "Eur Respir J",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Pathogenesis and therapy of 306 acute lung injury",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kitamura",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "The 74th Annual Meeting President Lecture",
            "volume": "74",
            "issn": "",
            "pages": "693--700",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Transepithelial migration of neutrophils",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Zemans",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "P"
                    ],
                    "last": "Colgan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "R"
                    ],
                    "last": "Downey",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "nisms and implications for acute lung injury",
            "authors": [],
            "year": 2009,
            "venue": "Am J Respir Cell Mol Biol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Transcriptional mechanisms of acute lung injury",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Malik",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Am J Physiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Innate immune receptors on neutrophils and their role in 313 chronic lung disease",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Koller",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bals",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Roos",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur J Clin Invest",
            "volume": "39",
            "issn": "7",
            "pages": "535--582",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Cynical hostility and stimulated Th1 and Th2 cy-315",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Janicki-Deverts",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Doyle",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Dual modulation of airway smooth muscle con",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ohta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hayashi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kanemaru",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Tar-320 gets",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Chung",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "675--81",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Airway inflammation and anti-protease defenses 322",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pant",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "H"
                    ],
                    "last": "Walters",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Griffiths",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Role of interleukin-13 in cancer",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "H"
                    ],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hogaboam",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Dover",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "H)2-type diseases",
            "authors": [],
            "year": 2006,
            "venue": "Vitam Horm",
            "volume": "74",
            "issn": "",
            "pages": "479--504",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "IL-13 receptors and signaling pathways: an evolving web",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Hershey",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "J Allergy Clin",
            "volume": "327",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Shoenfeld / Medicine in Drug Discovery xxx (xxxx) xxx metalloproteases, and serine proteases",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Solun",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Immunol",
            "volume": "183",
            "issn": "3",
            "pages": "1739--50",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "IL-13 effector functions",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Wynn",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Annu Rev Immunol",
            "volume": "21",
            "issn": "",
            "pages": "425--56",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Immunologic and inflammatory mechanisms that drive asthma progression 333 to remodeling",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Broide",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Allergy Clin Immunol",
            "volume": "121",
            "issn": "3",
            "pages": "560--70",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Making Sense of the Cytokine Storm: a conceptual framework for 335 understanding, diagnosing and treating hemophagocytic syndromes",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Scott",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Edward",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Pediatr Clin North",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Cytokine release syndrome in severe COVID-19: Science 17",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "June",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1126/science.abb8925"
                ]
            }
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "COVID-19) time musings: Our involvement in COVID-19 patho-340",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shoenfeld",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Corona",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "genesis, diagnosis, treatment and vaccine planning",
            "authors": [],
            "year": 2020,
            "venue": "Autoimmun Rev",
            "volume": "5",
            "issn": "",
            "pages": "341--102538",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Cytokine Storm in COVID-19 and Treatment",
            "authors": [
                {
                    "first": "Bili",
                    "middle": [],
                    "last": "Qing Ye 1",
                    "suffix": ""
                },
                {
                    "first": "Jianhua",
                    "middle": [],
                    "last": "Wang 1",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J In-343 fect",
            "volume": "",
            "issn": "20",
            "pages": "30165--30166",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "COVID-19: consider cytokine storm syndromes 345 and immunosuppression. The Lancet",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mehta",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Mcauley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "10229",
            "issn": "",
            "pages": "1033--1034",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Pathogenic Human Coronavirus Infections: Causes and 348 Consequences of Cytokine Storm and Immunopathology",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Immunopathol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Biochemical and Biological Attributes of Matrix Metallopro-351 teinases",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "Hu",
                    "middle": [],
                    "last": "Min",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Khalil",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Prog Mol Biol Transl Sci",
            "volume": "147",
            "issn": "",
            "pages": "1--73",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Matrix metalloproteinases in lung diseases",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ohbayashi",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Curr Protein Pept Sci",
            "volume": "3",
            "issn": "4",
            "pages": "409--430",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Biology of metalloproteinases",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Am\u0103linei",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "D"
                    ],
                    "last": "C\u0103runtu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "B\u0103lan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Rom J Morphol",
            "volume": "355",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Matrix metalloproteinases in lung: multiple, mul-357 tifarious, and multifaceted",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Greenlee",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Werb",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Kheradmand",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Physiol Rev",
            "volume": "87",
            "issn": "1",
            "pages": "69--98",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Induction and regulation of matrix metalloproteinase-12 359 in human airway smooth muscle cells",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Issa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Sukkar",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Respir Res",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Multiple roles of the extracellular matrix in inflammation",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Korpos",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sorokin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Matrix metalloproteinases (MMPs) and tissue in-363 hibitors of MMPs in the respiratory tract: potential implications in asthma and other 364 lung diseases",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Gueders",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Foidart",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Noel",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Eur J Pharmacol",
            "volume": "533",
            "issn": "1-3",
            "pages": "133--177",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Role of matrix metalloproteinases in the develop-366 ment of airway inflammation and remodeling",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lagente",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Manoury",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "N\u00e9nan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Braz J Med Biol Res",
            "volume": "38",
            "issn": "10",
            "pages": "367--1521",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Macrophage elastase (MMP-12): a pro-369 inflammatory mediator? Mem Inst Oswaldo Cruz",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "N\u00e9nan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Boichot",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lagente",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "",
            "volume": "100",
            "issn": "",
            "pages": "167--72",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Matrix metalloproteinases in destructive pulmonary pathol-371 ogy",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "T"
                    ],
                    "last": "Elkington",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Friedland",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Thorax",
            "volume": "61",
            "issn": "",
            "pages": "259--66",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Matrix metalloproteinases in respiratory dis-373 eases: from pathogenesis to potential clinical implications",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Oikonomidi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kostikas",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tsilioni",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr Med Chem",
            "volume": "16",
            "issn": "",
            "pages": "374--1214",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Salbutamol up-regulates matrix 376",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "O&apos;kane",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Mckeown",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "D"
                    ],
                    "last": "Perkins",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Matrix metalloproteinases in acute lung injury: me-379 diators of injury and drivers of repair",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Davey",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "F"
                    ],
                    "last": "Mcauley",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "O&apos;kane",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Eur Respir J",
            "volume": "38",
            "issn": "",
            "pages": "959--70",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Tissue kallikrein proteolytic cascade pathways in normal 381 physiology and cancer",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pampalakis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Sotiropoulou",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Biochim Biophys Acta",
            "volume": "1776",
            "issn": "1",
            "pages": "22--31",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Human plasma kallikrein-kinin system: physiological and 383 biochemical parameters. Cardiovascular & Hematological Agents in Medicinal Chemis-384 try",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Bryant",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Shariat-Madar",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "234--250",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Prekallikrein Activation in the Adult Respiratory Dis-386 tress Syndrome",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schapira",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Gardaz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Py",
                    "suffix": ""
                }
            ],
            "year": 1985,
            "venue": "Bull Eur Physiopathol Respir",
            "volume": "21",
            "issn": "3",
            "pages": "237--278",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "The Kallikrein-Kinin System in Asthma and Acute Respiratory Distress Syn-388",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Farmer",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "The Kinin System. Handbook of Immunopharmacology",
            "authors": [],
            "year": 1997,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Incidence of thrombotic complications 391 in critically ill ICU patients with COVID-19",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Klok",
                    "suffix": ""
                },
                {
                    "first": "Mjha",
                    "middle": [],
                    "last": "Kruip",
                    "suffix": ""
                },
                {
                    "first": "Njm",
                    "middle": [],
                    "last": "Van Der Meer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Thromb Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.thromres.2020.04.013"
                ]
            }
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ascenzi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bocedi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bolognesi",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Curr Protein Pept Sci",
            "volume": "4",
            "issn": "3",
            "pages": "231--51",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Review and application of serine protease inhibition in coronary artery bypass 396 graft surgery Am J Health Syst Pharm",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Engles",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "",
            "volume": "62",
            "issn": "",
            "pages": "9--14",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Aprotinin: a pharmacologic overview",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sypniewski",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Orthopedics",
            "volume": "27",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Systemic inflammatory response to coronary artery bypass graft surgery",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Hess",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Am",
            "volume": "400",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Bayer Temporarily Suspends Global Trasylol Marketing\" (PDF) (Press release)",
            "authors": [],
            "year": null,
            "venue": "Trasylol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Analogues in High-Risk Cardiac Surgery",
            "authors": [],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "358",
            "issn": "",
            "pages": "2319--2350",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "European Medicines Agency recommends lifting suspension of aprotinin",
            "authors": [],
            "year": null,
            "venue": "European",
            "volume": "409",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "The Nordic Group acquires rights to Trasylol\u00ae from Bayer HealthCare",
            "authors": [],
            "year": null,
            "venue": "The Nordic",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Danqing Zhang et al.Deep Vein Thrombosis in Hospitalized Pa-413",
            "authors": [
                {
                    "first": "Li",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Xiaokai",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF1": {
            "text": "79 eases. Since ALI/ARDS are so common in the United States and around the 80 world and the rapid and widespread of the COVID-19 has only aggravated 81 the existing problem, ALI/ARDS is still an unresolved medical issue. In 82 other words, new treatment modalities should be developed to further 83 improve the clinical outcomes [8].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "The pathophysiological mechanism of acute lung injury 89 In Covid-19 infection, epithelial damage is the initial event and hall-90 mark of the acute lung injury that initiates a cascade of local and/or 91 systemic processes leading to diffuse lung parenchymal damage [9,10]. 92 The focal airway inflammation produces an elevation of proinflammatory 93 cytokines and other inflammatory mediators and an over-expression of 94",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "cytokine storm is the overproduction of immune cells and their acti-120 vating compounds -cytokines, often associated with the release of activated 121 immune cells into the lungs. Resulting pneumonia and fluid accumulation 122 can lead to respiratory failure and may be contaminated with secondary 123 bacterial pneumonia. All of the above increase the risk of patient morbidity 124 and mortality [27-31]. 125 Matrix metalloproteinases (MMP) are part of a family of proteolytic zinc 126 enzymes. Till recently, more than twenty types of MMP have been recog-127 nized. They play a pivotal role in normal physiological conditions such as 128 embryogenesis, proliferation, angiogenesis, cell motility, wound healing, 129 degradation of the extracellular matrix, and in the different pathological 130 states [32].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "the involvement of MMP in the pathological processes 140 during ALI / ARDS have been found in the literature since the early 141 1990s. Nevertheless, research efforts failed to lead to effective pharma-142 cotherapy. Previously published works are devoted to the role of MMP 143 in the destructive pathologies of the lungs without considering their 144 function in the process of tissue repair, which was demonstrated in 145 later studies [41-43]. 146 Nonspecific inhibition of MMP has been shown to limit lung damage. 147 This suggests that there is a potential pharmacotherapeutic strategy for 148 treating early ALI / ARDS in patients with drugs that are non-specific 149 MMP inhibitors. Nonspecific inhibition of MMPs can have multiple effects 150 on other cellular processes and inflammatory mediators involved in lung 151 damage. In clinical practice doxycycline and tetracyclines, such as COL3 152 and CMT, are the most commonly used non-specific MMP inhibitors [44]. 153 Further investigations are required to fully understand the role of MMPs 154 in the pathogenesis of ALI/ARDS. These data are necessary to determine 155 what type of metalloproteinases should be inhibited, at which stage of the 156 disease, and what MMPs level may be optimal for the restoration of the ab-157 normal collagen.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "kallikrein system (KKS) plays an important and even critical role 161 in human physiology. Tissue kallikreins are a family of extracellular serine 162 proteases participating in complex proteolytic cascades, physiological func-163 tions, and various pathological processes [45]. KKS is responsible for the 164 release of the vasoactive pro-inflammatory neurotransmitter bradykinin 165 (BK). BK is a pro-inflammatory peptide, potent vasodilator, leading to 166 stable fluid accumulation in the interstitium. KKS is involved in the patho-167 genesis of inflammation, hypertension, endotoxemia, and coagulopathy. In 168 all these cases the elevated level of BK is a hallmark [46]. Schapira M. et al. 169 reported the activation of human plasma KKS in patients with ARDS [47]. 170 The kinin's level in the inflammatory environment is markedly in-171 creased. Thus, bradykinin (BK) can play an important role in initiating 172 and maintaining pathophysiological changes that occur in the lungs. Exper-173 imental trials on animals with ARDS demonstrated the beneficial effects of 174 selective kinin receptor antagonists and provided convincing evidence of 175",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "176COVID-19 may predispose to venous and arterial thromboembolism due 177 to the inflammatory process, hypoxia, immobilization, and diffuse intravas-178 cular coagulation. In a recently published study, Klok et al. enrolled 184 179 ICU patients with COVID-19 to evaluate the incidence of the composite out-180 come of symptomatic acute pulmonary embolism (PE), deep-vein thrombo-181 sis, ischemic stroke, myocardial infarction or systemic arterial embolism.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Deep vein thrombosis (DVT) followed by pulmonary embolization184 may result from increased thrombolysis and/or activation of KKS 185 in plasma. KKS activation leads to the generation of BK and tissue plas-186 minogen activator (tPA), two factors involved in ensuring smooth blood 187 flow through the arterial system. Thus, inhibition of kallikrein may be a 188 possible therapeutic target, given the effect of kallikrein on the plasma 189 production of bradykinin[46].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Aprotinin-possible therapeutic way to treat ALI/ARDS?191Aprotinin is a monomeric polypeptide and it is derived from bovine 192 lung tissue. It was initially named kallikrein inactivator and isolated from",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "Anderson et al. used sulfur mustard to induce oxidative and inflamma-241 tory lung injury in rats with further treatment with aprotinin, ilomastat, 242 or trolox. Aprotinin effectively prevented the increase in total protein and 243 IL-1 alfa levels in bronchial lavage fluid. Moreover, aprotinin maximally re-244 duced histopathological findings. These results suggest that therapy with 245 aprotinin may reduce the inflammatory response during experimental 246 lung damage[61].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "have seen and approved the final version of the manuscript.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "grateful to Prof.Ori Y. for his help, advice, and editorship 270 assistance.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic re-",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "In a recently published large cohort study from the Chinese Centre for Disease Control and Prevention that enrolled >70,000 patients with COVID-19, >44,000 of them showed a mild to critical severity range illness with the overall case-fatality rate of 2,3% and the highest up to 49% among Medicine in Drug Discovery xxx (xxxx) xxx\u204e Correspondence to: B. Solun Department of Internal Medicine D, Rabin Medical Center, Hasharon Hospital 7, Keren Kayemet St., Petah Tiqva, Israel. \u204e\u204e Correspondence to: Y. Shoenfeld Chaim Sheba Medical Center The Zabludowicz Center, for Autoimmune Diseases Tel Hashomer, 5265601, Israel. E-mail addresses: boriss2@clalit.org.il, (B. Solun), Yehuda.Shoenfeld@sheba.health.gov.il",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}